dalteparin has been researched along with Pressure Ulcer in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Pressure Ulcer: An ulceration caused by prolonged pressure on the SKIN and TISSUES when one stays in one position for a long period of time, such as lying in bed. The bony areas of the body are the most frequently affected sites which become ischemic (ISCHEMIA) under sustained and constant pressure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pannucci, CJ | 1 |
| Wachtman, CF | 1 |
| Dreszer, G | 1 |
| Bailey, SH | 1 |
| Portschy, PR | 1 |
| Hamill, JB | 1 |
| Hume, KM | 1 |
| Hoxworth, RE | 1 |
| Kalliainen, LK | 1 |
| Rubin, JP | 1 |
| Pusic, AL | 1 |
| Wilkins, EG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Minimization of Bleeding Complications Through Utilization of Perioperative Tranexamic Acid in Breast Surgery: A Randomized Double-blinded Placebo-controlled Trial[NCT02615366] | Phase 4 | 800 participants (Anticipated) | Interventional | 2016-02-29 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for dalteparin and Pressure Ulcer
| Article | Year |
|---|---|
The effect of postoperative enoxaparin on risk for reoperative hematoma.
Topics: Anticoagulants; Bariatric Surgery; Benchmarking; Clinical Protocols; Enoxaparin; Hematoma; Humans; M | 2012 |